
Region | Number of hospitals | Percentages % |
Hospital size (Number of staffed beds) |
||
Small |
||
< 50 |
0 | 0% |
50-99 |
0 | 0% |
Medium |
||
100-199 |
0 | 0% |
200-299 |
4 | 20% |
Large |
||
300-399 |
4 | 20% |
400-599 |
9 | 45% |
More that or equal 600 |
0 | 0% |
Very Large |
||
Medical Cities |
3 | 15% |
Missing No-Response |
4 | 20 % |
Ownership |
||
MOH-Hospitals |
20 | 100% |
Non-MOH Hospitals |
0 | 0% |
Privates |
0 | 0% |
Accreditation |
||
CIBAHI |
20 | 100% |
JCI |
5 | 25% |
Canada |
0 | 0% |
Table 1: Size Ownership and Accreditation of Respondents.
Region | Small < 100 n (%) |
Medium 100-299 n (%) |
Large 300-399 n (%) |
Large 400- > or = 600 n (%) |
Medical Cities n (%) |
Total n (%) |
Size Meter Sequre of TPN units (hospitals n = 19) |
||||||
> 30 |
0 (0) | 1 (5.26) | 0 (0) | 1 (5.26) | 0 (0) | 2 (10.52) |
21-30 |
0 (0) | 0 (0) | 0 (0) | 3 (15.78) | 1 (5.26) | 4 (21) |
11-20 |
0 (0) | 3 (15.78) | 3 (15.78) | 4 (21) | 1 (5.26) | 11 (57.9) |
1-10 |
0 (0) | 0 (0) | 1 (5.26) | 1 (5.26) | 0 (0) | 2 (10.52) |
No of Laminart Air Flow Hood (LAFH) (hospitals n = 20) |
||||||
> 6 |
0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
5-6 |
0 (0) | 0 (0) | 0 (0) | 1 (5) | 0 (0) | 1 (5) |
3-4 |
0 (0) | 1 (5) | 0 (0) | 2 (10) | 0 (0) | 1 (5) |
1-2 |
0 (0) | 3 (15) | 4 (20) | 6 (30) | 0 (0) | 13 (65) |
0 |
0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (5) | 1 (55) |
No of Automated compounding equipments (hospitals n = 20) |
||||||
> 6 |
0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
5-6 |
0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
3-4 |
0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
1-2 |
0 (0) | 3 (15) | 2 (10) | 6 (30) | 3 (15) | 14 (70) |
0 |
0 (0) | 1 (5) | 2 (10) | 3 (15) | 0 (0) | 6 (30) |
Table 2: TPN units size and equipments.
Region | Small 100 n (%) |
Medium 100-299 n (%) |
Large 300-399 n (%) |
Large 400- > or = 600 n (%) |
Medical Cities n (%) |
Total n (%) |
IV Adnixture-TPN-Oncolgy Preprartion Program avaliable (hospitals n = 20) |
||||||
100 % applications |
0 (0) | 1 (5) | 1 (5) | 3 (15) | 2 (10) | 7 (35) |
75 % applications |
0 (0) | 0 (0) | 0 (0) | 1 (5) | 1 (5) | 2 (10) |
50 % applications |
0 (0) | 0 (0) | 0 (0) | 1 (5) | 0 (0) | 1 (5) |
25 % applications |
0 (0) | 0 (0) | 0 (0) | 1 (5) | 0 (0) | 1 (5) |
0 % applications |
0 (0) | 3 (15) | 3 (15) | 3 (15) | 0 (0) | 9 (45) |
TPN Peparations |
||||||
100 % of TPN orders prepare by pharmacists or pharmacy technicians |
0 (0) | 4 (20) | 4 (20) | 8 (40) | 3 (15) | 19 (95) |
75 % of TPN orders prepare by pharmacists or pharmacy technicians |
0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
50 % of TPN orders prepare by pharmacists or pharmacy technicians |
0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
25 % of TPN orders prepare by pharmacists or pharmacy technicians |
0 (0) | 0 (0) | 0 (0) | 1 (5) | 0 (0) | 1 (5) |
0 % of TPN orders prepare by pharmacists or pharmacy technicians |
0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
TPN Automated Preparations (hospitals n = 20) |
||||||
100 % of TPN Preparations by Automtic Compounding |
0 (0) | 4 (30) | 4 (20) | 9 (45) | 2 (10) | 19 (95) |
75 % of TPN Preparations by Automtic Compounding |
0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
50 % of TPN Preparations by Automtic Compounding |
0 (0) | 0 (0) | 0 (0) | 1 (0) | 0 (0) | 1 (5) |
25 % of TPN Preparations by Automtic Compounding |
0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
Not Cover hospital wards |
0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
TPN preparation label contains all active ingredient (hospitals n = 20) |
||||||
100% applications |
0 (0) | 4 (20) | 4 (20) | 8 (40) | 3 (15) | 19 (95) |
75% applications |
0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
50% applications |
0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
2 % applications |
0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
0% applications |
0 (0) | 0 (0) | 0 (0) | 1 (5) | 0 (0) | 1 (5) |
Use ca ph compatibility chart to prevent TPN precipitation (hospitals n = 20) |
||||||
100% Prescriptions |
0 (0) | 2 (10) | 3 (15) | 7 (35) | 3 (15) | 15 (75) |
75% Prescriptions |
0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
50% Prescriptions |
0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
25% Prescriptions |
0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
0% Prescriptions |
0 (0) | 2 (10) | 1 (5) | 2 (10) | 0 (0) | 5 (25) |
Table 3: TPN prepration.
Region | Small < 100 n (%) |
Medium 100-299 n (%) |
Large 300-399 n (%) |
Large 400- > or = 600 n (%) |
Medical Cities n (%) |
Total n (%) |
TPN Central line administration (hospitals n = 20) |
||||||
100% applications |
0 (0) | 3 (15) | 2 (15) | 5 (25) | 2 (10) | 12 (65) |
75% applications |
0 (0) | 1 (5) | 1 (5) | 2 (10) | 1 (5) | 5 (25) |
50 % applications |
0 (0) | 0 (0) | 1 (5) | 0 (0) | 0 (0) | 1 (5) |
25 % applications |
0 (0) | 0 (0) | 0 (0) | 1 (5) | 0 (0) | 0 (5) |
0 % applications |
0 (0) | 0 (0) | 0 (0) | 1 (5) | 0 (0) | 0 (5) |
TPN Prescriptions (hospitals n = 20) |
||||||
100% applications |
0 (0) | 4 (20) | 3 (15) | 5 (15) | 3 (15) | 15 (75) |
75% applications |
0 (0) | 0 (0) | 0 (0) | 1 (5) | 0 (0) | 1 (5) |
50 % applications |
0 (0) | 0 (0) | 0 (0) | 2 (10) | 0 (0) | 2 (10) |
25% applications |
0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
0% applications |
0 (0) | 0 (0) | 1 (5) | 1 (5) | 0 (0) | 2 (10) |
Table 4: TPN administration.
Region | Small < 100 n (%) |
Medium 100-299 n (%) |
Large 300-399 n (%) |
Large 400- > or = 600 n (%) |
Medical Cities n (%) |
Total n (%) |
TPN – TQM Applications (hospitals n = 20) |
||||||
100% Prescriptions |
0 (0) | 2 (10) | 1 (5) | 4 (20) | 2 (10) | 9 (45) |
75 % Prescriptions |
0 (0) | 2 (10) | 0 (0) | 0 (0) | 0 (0) | 2 (10) |
50% Prescriptions |
0 (0) | 0 (0) | 0 (0) | 1 (5) | 0 (0) | 1 (5) |
25% Prescriptions |
0 (0) | 0 (0) | 1 (5) | 2 (10) | 0 (0) | 3 (15) |
0 % Prescriptions |
0 (0) | 0 (0) | 2 (10) | 2 (10) | 1 (5) | 5 (25) |
TPN Policy and Procedures and Job descriptions (hospitals n = 20, may contain more than one answers) |
||||||
Adults |
0 (0) | 1 (5) | 3 (15) | 6 (30) | 3 (15) | 13 (65) |
Pediatrics |
0 (0) | 3 (15) | 2 (10) | 7 (35) | 1 (5) | 3 (65) |
Neonates |
0 (0) | 4 (20) | 1 (5) | 7 (35) | 0 (0) | 12 (60) |
Table 5: TPN Quality Management.
Region | Small < 100 n (%) |
Medium 100–299 n (%) |
Large 300–399 n (%) |
Large 400- > or = 600 n (%) |
Medical Cities n (%) |
Total n (%) |
Pharmacists has BCNSP Avaliable (hospitals n = 20) |
||||||
100% Pharmacists |
0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
75% Pharmacists |
0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
50% Pharmacists |
0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
25% Pharmacists |
0 (0) | 1 (5) | 0 (0) | 0 (0) | 0 (0) | 1 (5) |
0% Pharmacists |
0 (0) | 3 (0) | 4 (20) | 9 (45) | 3 (15) | 19 (45) |
Pharmacist had accredited TPN Training Certificate (hospitals n = 20) |
||||||
100% Pharmacists |
0 (0) | 1 (5) | 0 (0) | 3 (15) | 0 (0) | 4 (20) |
75% Pharmacists |
0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
50% Pharmacists |
0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (5) | 1 (5) |
25% Pharmacists |
0 (0) | 1 (5) | 1 (5) | 3 (15) | 1 (5) | 6 (30) |
0% Pharmacists |
0 (0) | 2 (10) | 3 (15) | 3 (15) | 1 (5) | 9 (45) |
Table 6: TPN staff qulification.
Region | Small < 100 n (%) |
Medium 100-299 n (%) |
Large 300-399 n (%) |
Large 400- > or = 600 n (%) |
Medical Cities n (%) |
Total n (%) |
TPN References (hospitals n = 20) |
||||||
100% of them avaliable |
0 (0) | 0 (0) | 1 (5) | 1 (5) | 1 (5) | 3 (15) |
75% of them avaliable |
0 (0) | 0 (0) | 1 (5) | 1 (5) | 2 (10) | 4 (20) |
50% of them avaliable |
0 (0) | 3 (15) | 1 (5) | 5 (25) | 0 (0) | 9 (45) |
25% of them avaliable |
0 (0) | 1 (5) | 1 (5) | 1 (5) | 0 (0) | 1 (5) |
0% of them avaliable |
0 (0) | 0 (0) | 0 (0) | 1 (5) | 0 (0) | 1 (5) |
Pharmacist attend national and international TPN Conference (hospitals n = 20) |
||||||
100% Pharmacists |
0 (0) | 1 (5) | 0 (0) | 2 (10) | 2 (10) | 5 (25) |
75% Pharmacists |
0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
50% Pharmacists |
0 (0) | 1 (5) | 1 (5) | 4 (20) | 1 (5) | 7 (35) |
25% Pharmacists |
0 (0) | 1 (5) | 1 (5) | 1 (5) | 0 (0) | 3 (15) |
0% Pharmacists |
0 (0) | 1 (5) | 2 (10) | 2 (10) | 0 (0) | 5 (25) |
TPN Lectures given to Physicians and Nurses (hospitals n = 20) |
||||||
100% attened of Physicians and Nurses |
0 (0) | 0 (0) | 0 (0) | 1 (5) | 0 (0) | 1 (5) |
75% attened of Physicians and Nurses |
0 (0) | 0 (0) | 0 (0) | 1 (5) | 1 (5) | 2 (10) |
50% attened of Physicians and Nurses |
0 (0) | 1 (5) | 1 (5) | 3 (15) | 1 (5) | 6 (30) |
25% attened of Physicians and Nurses |
0 (0) | 0 (0) | 0 (0) | 1 (5) | 0 (0) | 1 (5) |
0 % attened of Physicians and Nurses |
0 (0) | 3 (15) | 3 (15) | 3 (15) | 1 (5) | 10 (50) |
TPN Lectures given to Pharmacists and Pharmacy Tecnicians (hospitals n = 20) |
||||||
100 % attened of Pharmacist and Pharmacy Tecnicians |
0 (0) | 0 (0) | 0 (0) | 3 (15) | 1 (5) | 4 (20) |
75 % attened of Pharmacist and Pharmacy Tecnicians |
0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (5) | 1 (5) |
50 % attened of Pharmacist and Pharmacy Tecnicians |
0 (0) | 0 (0) | 1 (5) | 4 (20) | 1 (5) | 6 (30) |
25 % attened of Pharmacist and Pharmacy Tecnicians |
0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
0 % attened of Pharmacist and Pharmacy Tecnicians |
0 (0) | 4 (20) | 3 (15) | 2 (10) | 0 (0) | 9 (45) |
Table 7:TPN Education and Training.
- Joint Commission International Accreditation Standards for Hospitals. Fifth Edition Joint Commission Resources (2014).
- American Society of Health-System Pharmacists. “ASHP Guidelines: minimum standard for ambulatory care pharmacy practice”. American Journal of Health-System Pharmacy 72 (2015): 1221-1236.
- Saudi Central Board for Accreditation of Healthcare Institutions. “National Hospital Standards”. 2015 Third Edition. CBAHI publications (2015).
- Boullata JI., et al. “A.S.P.E.N. Clinical Guidelines: Parenteral Nutrition Ordering, Order Review, Compounding, Labeling, and Dispensing.” Journal of Parenteral and Enteral Nutrition 38.3 (2014): 334-377.
- Alomi YA. “National Pharmacy Practice Programs at Ministry of Health in Saudi Arabia”. Journal of Pharmacy & Pharmaceutical Sciences 1.2 (2015): 17-18.
- Alomi YA., et al. “Strategic Plan of General Administration of Pharmaceutical Care at Ministry of Health in Saudi Arabia 2012 - 2022”. Journal of Pharmacy & Pharmaceutical Sciences 1.3 (2015): 1-8.
- Pedersen CA., et al. “ASHP national survey of pharmacy practice in hospital settings: Dispensing and Administration”. American Journal of Health-System Pharmacy 72 (2015): 1119-1137.
- Pedersen CA., et al. “ASHP national survey of pharmacy practice in hospital settings: Prescribing and transcribing”. American Journal of Health-System Pharmacy 71 (2013): 1924-1942.
- Pedersen CA., et al. “ASHP national survey of pharmacy practice in hospital settings: Drug monitoring and patient education”. American Journal of Health-System Pharmacy 70 (2013): 787-803.
- Alsultan MS., et al. “Hospital pharmacy practice in Saudi Arabia: Prescribing and transcribing in the Riyadh region”. Saudi Pharmaceutical Journal 20.3 (2012): 203-210.
- Alsultan MS., et al. “Hospital pharmacy practice in Saudi Arabia: Dispensing and administration in the Riyadh region”. Saudi Pharmaceutical Journal 20.4 (2012): 307-315.
- Alsultan MS., et al. “Hospital pharmacy practice in Saudi Arabia: Drug monitoring and patient education in the Riyadh Region”. Saudi Pharmaceutical Journal 21.4 (2013): 361-370.
- Neal BC., et al. “Compliance with safe practices for preparing parenteral nutrition formulations”. American Journal of Health-System Pharmacy 59(2002): 264-269.
- Hassig TB., et al. “Clinical Management Strategies and Implications for Parenteral Nutrition Drug Shortages in Adult Patients”. Pharmacotherapy 34.1 (2014): 72-84.
- American Society of Health-System Pharmacists. “ASHP guidelines on the safe use of automated compounding devices for the preparation of parenteral nutrition admixtures”. American Journal of Health-System Pharmacy 57 (2000): 1343-1348.
- Canada T., et al. “Safe Practices for Parenteral Nutrition”. Journal of Parenteral and Enteral Nutrition 28.6 (2004): S39-S70.
- Ayers P., et al. “ASPEN Parenteral Nutrition Safety Consensus Recommendations”. Scholarship and Professional Work - COPHS (2014). Paper 1.
- Boullata JI., et al. “ASPEN Clinical Guidelines: Parenteral Nutrition Ordering, Order Review, Compounding, Labeling, and Dispensing”. Journal of Parenteral and Enteral Nutrition (2014): 1-44.
Journal Menu
PubMed Indexed Article
EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.
PMID: 31143884 [PubMed]
PMCID: PMC6536005
EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.
PMID: 31565701 [PubMed]
PMCID: PMC6764777
EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.
PMID: 27747317 [PubMed]
PMCID: PMC5065347
EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?
PMID: 31460519 [PubMed]
PMCID: PMC6711478
EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?
PMID: 30215059 [PubMed]
PMCID: PMC6133253
EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.
PMID: 30417173 [PubMed]
PMCID: PMC6226033
EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.
PMID: 30264037 [PubMed]
PMCID: PMC6155992
EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.
PMID: 30198026 [PubMed]
PMCID: PMC6124505
EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.
PMID: 30294723 [PubMed]
PMCID: PMC6169793
EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs
PMID: 29285526 [PubMed]
PMCID: PMC5743211
EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique
PMID: 29911204 [PubMed]
PMCID: PMC5999047
EC Microbiology
Macrophages and the Viral Dissemination Super Highway
PMID: 26949751 [PubMed]
PMCID: PMC4774560
EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.
PMID: 27390782 [PubMed]
PMCID: PMC4933318
EC Microbiology
Reactive Oxygen Species in HIV Infection
PMID: 28580453 [PubMed]
PMCID: PMC5450819
EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population
PMID: 26280024 [PubMed]
PMCID: PMC4533840
EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis
PMID: 28066845 [PubMed]
PMCID: PMC5214344
EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology
PMID: 28936490 [PubMed]
PMCID: PMC5604476
EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia
PMID: 28713879 [PubMed]
PMCID: PMC5510658
EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature
PMID: 28133641 [PubMed]
PMCID: PMC5267489
EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling
PMID: 29333536 [PubMed]
PMCID: PMC5766278
EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.
PMID: 31032493 [PubMed]
PMCID: PMC6483108
EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.
PMID: 30957099 [PubMed]
PMCID: PMC6448571
EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.
PMID: 30101228 [PubMed]
PMCID: PMC6086333
EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.
PMID: 31080964 [PubMed]
PMCID: PMC6508883
EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.
PMID: 31093608 [PubMed]
PMCID: PMC6513001
EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.
PMID: 31552397 [PubMed]
PMCID: PMC6758937
EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.
PMID: 31681909 [PubMed]
PMCID: PMC6824723
EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.
PMID: 31681910 [PubMed]
PMCID: PMC6824726
EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.
PMID: 31528859 [PubMed]
PMCID: PMC6746603
EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?
PMID: 31276119 [PubMed]
PMCID: PMC6604646
EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.
PMID: 31406965 [PubMed]
PMCID: PMC6690616
EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.
PMID: 31517314 [PubMed]
PMCID: PMC6741290
EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.
PMID: 31633124 [PubMed]
PMCID: PMC6800226
EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.
PMID: 29662969 [PubMed]
PMCID: PMC5898812
EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.
PMID: 30215058 [PubMed]
PMCID: PMC6133268
News and Events
February Issue Release
We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the February issue of respective journals and the latest articles can be viewed on the current issue pages.
Submission Deadline for Upcoming Issue
ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before February 17, 2023.
Certificate of Publication
ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.
Best Article of the Issue
Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.
Certifying for Review
ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.
Latest Articles
The latest articles will be updated immediately on the articles in press page of the respective journals.